Drug Profile
Research programme: diabetes therapy - PhytoMedical Technologies
Alternative Names: Cynnamon-derived type A-1 polyphenols - PhytoMedical TechnologiesLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Iowa State University
- Developer PhytoMedical Technologies
- Class Polyphenols
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in USA
- 12 Mar 2007 Data from a clinical study in patients with Type-2 diabetes added to the adverse events and Diabetes therapeutic trials sections
- 13 Jun 2006 PhytoMedical Technologies and Iowa State University has entered into an exclusive licensing agreement to develop, market and distribute novel synthesised compounds derived from type A-1 polyphenols